USA Today, August 12, 2013

The Food and Drug Administration has announced a voluntary nationwide recall of all sterile products from a Texas compounding pharmacy, the latest in a series of recalls since last year's outbreak of fungal meningitis. Fifteen patients at two Texas hospitals have developed bacterial bloodstream infections after receiving injections from Specialty Compounding from Cedar Park, Texas, the FDA said Sunday. The patients had received infusions of a mineral supplement called calcium gluconate injections. It can be used as part of treatment for cardiac arrest, to treat calcium deficiency, or to treat very high potassium levels.
Facebook icon
LinkedIn icon
Twitter icon